|
|
.
See Category: Neoplasms
ICD-10 (CM) Code and Descriptor
|
D01.3 |
Carcinoma in situ of anus and anal canal
|
D013 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 54.35%
|
17.97%
|
10.26%
|
4.99%
|
4.04%
|
1.93%
|
1.87%
|
1.10%
|
0.89%
|
0.61%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for D01.3*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
867
|
1,776
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
629
|
18,832
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
587
|
588
|
|
J3010
|
FENTANYL CITRATE INJECTION |
497
|
682
|
|
J2405
|
ONDANSETRON HCL INJECTION |
429
|
1,815
|
|
88342
|
IMHCHEM/IMCYTCHM 1ST ANTB |
356
|
497
|
|
J2250
|
INJ MIDAZOLAM HYDROCHLORIDE |
347
|
730
|
|
J3490
|
DRUGS UNCLASSIFIED INJECTION |
310
|
1,380
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
295
|
1,783
|
|
J7120
|
RINGERS LACTATE INFUSION |
257
|
303
|
|
46922
|
EXCISION OF ANAL LESION(S) |
211
|
211
|
|
88112
|
CYTOPATH CELL ENHANCE TECH |
186
|
187
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
181
|
201
|
|
46607
|
DIAGNOSTIC ANOSCOPY & BIOPSY |
178
|
178
|
|
A9270
|
NON-COVERED ITEM OR SERVICE |
176
|
380
|
|
46600
|
DIAGNOSTIC ANOSCOPY SPX |
174
|
174
|
|
J2001
|
LIDOCAINE INJECTION |
144
|
1,529
|
|
88341
|
IMHCHEM/IMCYTCHM EA ADD ANTB |
117
|
202
|
|
J1885
|
KETOROLAC TROMETHAMINE INJ |
105
|
186
|
|
C9290
|
INJ, BUPIVACAINE LIPOSOME |
99
|
25,144
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
D01.3 related to the following DRG Codes:
374-376
|
